Dec 29 (Reuters) - Ultragenyx Pharmaceutical (RARE.O), opens new tab said on Monday that late-stage studies showed its drug for a type of genetic bone disease failed to reduce the number of fractures ...
That unmistakable sound of bone giving way under pressure sends immediate dread through anyone who hears it. Broken bones account for millions of medical visits annually in the United States alone, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback